Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Short term effectiveness of a novel nutraceutical for the management of hypercholesterolemia in patients with low to moderate cardiovascular risk: a multicenter primary care observational
Anno:
2023
Purpose: Increasing evidence reinforces the benefits of reduction of low-density lipoprotein (LDL-C) levels on cardiovascular outcomes. Different targets are suggested based on cardiovascular risk (CVR). According to the current European guidelines, a goal of LDL-C≤ 115mg/dL is desirable for patients with low-moderate CVR. However, a high percentage of these…
Liver stiffness relates to an increased risk for atherosclerotic cardiovascular disease in patients with non-alcoholic fatty liver disease
Anno:
2023
Aim: non-alcoholic fatty liver disease (NAFLD) is one of the end-target organ damage of lipid metabolism alterations. There are no clear data about the connection between steatohepatitis and heart involvement. However, many risk factors overlap in both diseases. Therefore, a possible connection between the two organs may be plausible….